These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 26541393

  • 1. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA, Yao X, Deshmukh AJ, Van Houten H, Sangaralingham LR, Siontis KC, Piccini JP, Asirvatham SJ, Friedman PA, Packer DL, Gersh BJ, Shah ND.
    J Am Heart Assoc; 2015 Nov 05; 4(11):. PubMed ID: 26541393
    [Abstract] [Full Text] [Related]

  • 2. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
    Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP.
    Circ Arrhythm Electrophysiol; 2019 Dec 05; 12(12):e007612. PubMed ID: 31830822
    [Abstract] [Full Text] [Related]

  • 3. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
    Riley MP, Zado E, Hutchinson MD, Lin D, Bala R, Garcia FC, Callans DJ, Cooper JM, Verdino RJ, Dixit S, Marchlinski FE.
    J Cardiovasc Electrophysiol; 2014 Jun 05; 25(6):591-6. PubMed ID: 24533561
    [Abstract] [Full Text] [Related]

  • 4. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.
    Heart Rhythm; 2015 Apr 05; 12(4):681-6. PubMed ID: 25546809
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP, Saba S, Zhang Y, Hernandez I.
    J Am Heart Assoc; 2018 Jan 04; 7(1):. PubMed ID: 29301756
    [Abstract] [Full Text] [Related]

  • 6. Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry.
    Thompson LE, Maddox TM, Lei L, Grunwald GK, Bradley SM, Peterson PN, Masoudi FA, Turchin A, Song Y, Doros G, Davis MB, Daugherty SL.
    J Am Heart Assoc; 2017 Jul 19; 6(7):. PubMed ID: 28724655
    [Abstract] [Full Text] [Related]

  • 7. [Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: results from the German Ablation Registry].
    Moser J, Kuck KH, Andresen D, Spitzer SG, Hoffmann E, Schumacher B, Eckardt L, Brachmann J, Lewalter T, Hochadel M, Senges J, Willems S, Hoffmann BA.
    Dtsch Med Wochenschr; 2014 Sep 19; 139(39):1923-8. PubMed ID: 25225860
    [Abstract] [Full Text] [Related]

  • 8. Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.
    Kochhäuser S, Alipour P, Haig-Carter T, Trought K, Hache P, Khaykin Y, Wulffhart Z, Pantano A, Tsang B, Birnie D, Verma A.
    J Cardiovasc Electrophysiol; 2017 Mar 19; 28(3):273-279. PubMed ID: 27933666
    [Abstract] [Full Text] [Related]

  • 9. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 10. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, AF Ablation Frontier Registry.
    Circ J; 2019 Nov 25; 83(12):2418-2427. PubMed ID: 31619591
    [Abstract] [Full Text] [Related]

  • 11. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    Europace; 2014 Feb 25; 16(2):195-201. PubMed ID: 24036378
    [Abstract] [Full Text] [Related]

  • 12. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.
    Circ Arrhythm Electrophysiol; 2013 Oct 25; 6(5):868-74. PubMed ID: 24047706
    [Abstract] [Full Text] [Related]

  • 13. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS, Larsen TB, Deharo JC, Rossvoll O, Dagres N, Todd D, Pison L, Proclemer A, Purefellner H, Blomström-Lundqvist C, Scientific Initiatives Committee of European Heart Rhythm Association (EHRA).
    Europace; 2015 Jun 25; 17(6):986-93. PubMed ID: 26023177
    [Abstract] [Full Text] [Related]

  • 14. Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Giehm-Reese M, Johansen MN, Kronborg MB, Jensen HK, Gerdes C, Kristensen J, Johannessen A, Jacobsen PK, Djurhuus MS, Hansen PS, Riahi S, Nielsen JC.
    Int J Cardiol; 2021 Jun 15; 333():110-116. PubMed ID: 33647366
    [Abstract] [Full Text] [Related]

  • 15. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.
    Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, Gersh BJ, Shah ND, Noseworthy PA.
    J Am Heart Assoc; 2016 Feb 23; 5(2):. PubMed ID: 26908412
    [Abstract] [Full Text] [Related]

  • 16. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC, Fan J, Askari M, Heidenreich PA, Keung E, Raitt MH, Piccini JP, Ziegler PD, Turakhia MP.
    Circulation; 2019 May 28; 139(22):2502-2512. PubMed ID: 30880434
    [Abstract] [Full Text] [Related]

  • 17. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L, Lecoq C, Clementy N, Bernard A, Angoulvant D, Ivanes F, Babuty D, Lip GY.
    Chest; 2016 Apr 28; 149(4):960-8. PubMed ID: 26425935
    [Abstract] [Full Text] [Related]

  • 18. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J, Cerrud-Rodriguez RC, Diaz JC, Rodriguez D, Arshad S, Alviz I, Cerna L, Rios S, Monhanty S, Natale A, Garcia MJ, Di Biase L.
    J Cardiovasc Electrophysiol; 2019 Aug 28; 30(8):1250-1257. PubMed ID: 31257677
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.
    Zhao J, Zhou D, Chen M, Zhuo C, Lin Z, Zheng L, Wang Q.
    J Cardiovasc Med (Hagerstown); 2020 Mar 28; 21(3):200-208. PubMed ID: 31977539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.